Alkali Or Alkaline Earth Chloride (e.g., Barium Or Lithium Chloride, Etc.) Patents (Class 424/677)
-
Publication number: 20080175924Abstract: An assay for a GCH1 allele and associated genotype for the screening, prediction, diagnosis, prognosis, treatment and treatment response of psychiatric, neuropsychiatric, and neurological disorders, such as schizophrenia, schizoaffective disorder and bipolar disorder, and for defining treatments of such disorders. The presence of a variant in the GCH1 gene, alone or in conjunction with a measurement of low or altered biopterin, or altered BH4 system measures, is used to screen for or diagnose subjects at high risk for developing a psychiatric, neuropsychiatric, or neurological disorders. The assay of the GCH1 genotype, with or without biopterin or a BH4 or BH4 system assay, may also be used to determine antipsychotic or mood stabilizer medication, as well as other treatments. For subjects with an impaired BH4 system, treatments to increase or normalize biopterin, BH4, or the BH4 system can also be used, such as BH4 supplementation, lithium treatment, phenylalanine treatment, or other treatments and therapies.Type: ApplicationFiled: October 17, 2007Publication date: July 24, 2008Applicant: THE RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC.Inventors: James D. Clelland, Catherine L. Clelland
-
Patent number: 7387799Abstract: The present invention relates to an anti-bacterial, anti-viral, and anti-fungus composition, its preparation and use. The composition of the present invention mainly includes the following three ingredients in an adequate ratio: (A) a metal compound having catalytic function; (B) ionic compound, and (C) an additive. The anti-bacterial, anti-virus, and anti-fungus composition of the present invention is capable of destroying viruses as well as killing bacterial and fungi. Therefore, the composition can be formulated as an aerosol and a film for applying to protection devices such as respirators, masks, gloves, filters, condoms, etc. The present composition can also be used in household, vehicle, hospital, school, restaurant, hotel, internet coffee shop for applying to filter of air-conditioner, tap, stool, interior of elevator and its keyboard.Type: GrantFiled: July 29, 2003Date of Patent: June 17, 2008Assignee: Well-Being Biochemical Corp.Inventors: Jih-Ru Hwu, Shwu-Chen Tsay
-
Publication number: 20080124390Abstract: Once daily pharmaceutical compositions containing lithium carbonate in the form of coated granules.Type: ApplicationFiled: October 29, 2007Publication date: May 29, 2008Inventor: Giuliu Tarro
-
Patent number: 7378111Abstract: Provided is a novel use of therapeutic concentrations of an inhibitor of glycogen synthase kinase-3 (GSK-3), including lithium or any other GSK-3 inhibitor, to block, reduce or inhibit processing of amyloid precursor proteins to beta-amyloid (A?) peptides, which are now believed to be the principal cause of Alzheimer's disease, thereby providing methods useful for the prevention, inhibition or reversal of the disease. Also provided are methods of using agents that specifically target the ? isoform of GSK-3, which is responsible for APP processing, making such selective GSK-3?-specific inhibitors especially useful in the treatment, prevention, and possible reversal of Alzheimer's disease. Further provided are kits and screening methods associated with the present methods.Type: GrantFiled: February 19, 2003Date of Patent: May 27, 2008Assignee: The Trustees of the University of PennsylvaniaInventors: Christopher J. Phiel, Christina A. Wilson, Virginia M-Y. Lee, Peter S. Klein
-
Publication number: 20080118577Abstract: The present invention provides a composition capable of regulating the activity of autonomic nerves, by acting on these nerves, so as to maintain the homeostasis or alleviate disturbed homeostasis in an animal, wherein the above composition can be obtained from a naturally occurring substance in the nature by a simple process. The seawater mineral-containing composition of the present invention is characterized in that it contains seawater minerals obtained by treating seawater and is capable of regulating autonomic nerves. The seawater mineral-containing composition of the present invention preferably has a magnesium concentration of 70 mg/L or higher and a sodium concentration of 3 mg/L or lower.Type: ApplicationFiled: May 6, 2005Publication date: May 22, 2008Inventors: Toshio Moritani, Kayo Saito
-
Patent number: 7345029Abstract: The present invention relates to a solution for peritoneal dialysis, consisting of at least two single solutions which are combined after a heat sterilization and are administered to a patient, the first single solution containing an osmotic and the second single solution containing a buffer, and one of these single solutions or another single solution containing electrolyte salts. The avoidance of a glucose-like degradation as well as hydrolysis during sterilization and storage while maintaining a neutral mixture pH is achieved according to the invention by the osmotic comprising a glucose polymer and/or glucose polymer derivative, and the pH of the first single solution being between 3.5 and 5.0. The present invention further relates to a twin-chambered pouch consisting of a plastic pouch with at least one first chamber and a second chamber, the first single solution being included in the first chamber and the second single solution being included in the second chamber.Type: GrantFiled: April 18, 2003Date of Patent: March 18, 2008Assignee: Fresenius Medical Care Deutschland GmbHInventor: Thomas Zimmeck
-
Patent number: 7241460Abstract: The invention provides a method of treatment of a human or non-human subject to combat sub-dermal soft tissue pain therein, said method comprising administering to a subject in need thereof an effective amount of a physiologically tolerable strontium compound.Type: GrantFiled: September 27, 2002Date of Patent: July 10, 2007Assignee: Santosolve ASInventors: Egil Jellum, Bjørn Jarl Fagerlund, Clas Magne Kjølberg, Jo Klaveness
-
Patent number: 7108848Abstract: A gel formulation is combined with a fungicidal concentrate which is a liquid mixture of about 1.2 to 16 ml parts by volume of ultra pure water having an electrical resistance of 16–26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 mho with about 1.2 to 16 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943, together with one liter of a gel formulation ingredient containing 10% by weight urea, based on the weight of the gel formulation. The fungicidal liquid concentrate is applied directly to a fungal nail to soften the fungal nail and control the growth of fungi.Type: GrantFiled: July 20, 2004Date of Patent: September 19, 2006Assignee: Aqua Med, Inc.Inventors: John D. Young, Alberto Hoyo
-
Patent number: 7078059Abstract: The invention provides a method for enhancing bone formation, inhibiting osteoclastic differentiation and/or activating osteoblastic differentiation whereby to manage, treat or achieve prophylaxis of bone disease which comprises administering to a human or animal subject suffering from, or susceptible to bone disease a therapeutically or prophylactically effective amount of a lanthanum compound.Type: GrantFiled: June 26, 2001Date of Patent: July 18, 2006Assignee: Shire Holdings AGInventors: Nigel D. Atherton, Joseph William Totten, Michael David Gaitonde
-
Patent number: 7029705Abstract: A method is disclosed of practicing nasal hygiene comprising the steps of applying to a person's nostril a non-irritating hygienic composition consisting essentially of a product of compounding under homogenizing conditions water, 0.01% to 5% by weight, as chlorine dioxide, of a source of chlorine dioxide; 0.01% to 3% by weight of at least one olfactory stimulant, 0 to 5% by weight of at least one fixative compound less volatile than the olfactory stimulant 0.1 to 2.5% by weight of at least one inorganic salt selected from the group consisting of alkali metal chloride, alkali metal bicarbonate, and alkali metal chlorate; and 0.0002 to 0.006% (as aluminum) by weight of at least one water soluble aluminum compound, provided that the total concentration of inorganic salt is in the range from 0.6% by weight to 2.5% by weight, holding the composition within the nostril for a hygienic holding period, and discharging the composition from the treated nostril.Type: GrantFiled: July 30, 2003Date of Patent: April 18, 2006Inventor: Allan H. Fuhr
-
Patent number: 7001612Abstract: A composition for the relief of heat stress, particularly for restoration of electrolyte balance due to passive exposure to heat resulting in excessive transpiration/perspiration, without strenuous physical activity, contains predetermined levels of selected electrolytes including, in part by weight, sodium ion not exceeding 250 parts, at least 100 parts of potassium ion, at least 100 parts of magnesium ion, and carbohydrates not exceeding 2.5% by weight, as needed for organoleptic purposes only. The composition can further include up to 30 parts of zinc, up to 10 parts of manganese, and from 65 to 400 parts of calcium. Furthermore, the composition can contain oligoelements, dermoprotective vitamins and anti-oxidants so as to compensate for the chemical changes which might occur in the skin of a person passively exposed to heat.Type: GrantFiled: February 13, 2002Date of Patent: February 21, 2006Assignee: All Sun HSF Company LimitedInventors: Fausto Armonti, Donato Mitola, Jacobus C. Samson
-
Patent number: 6994873Abstract: This invention refers to: multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional release granules, suitable for once-a-day administration also at high strengths of Lithium salts, and to the preparation process of said formulations.Type: GrantFiled: February 4, 2002Date of Patent: February 7, 2006Assignee: Valpharma S.A.Inventors: Roberto Valducci, Tiziano Alighieri, Serozh Avanessian
-
Patent number: 6932966Abstract: A skin treatment mixture for treating pierced skin such as that resulting from a body piercing procedure includes sea salt, lysozyme and reconstituted ocean water. The reconstituted ocean water preferably is the product of reverse osmosis of water. The skin treatment mixture preferably additionally includes sodium benzoate to act as a preservative. A method of producing a skin treatment mixture includes the steps of providing a quantity of purified water; adding a quantity of sea salt to the quantity of purified water; boiling the purified water and sea salt; cooling the purified water and sea salt; adding a quantity of lysozyme to the purified water and sea salt; sterilizing the mixture and testing it for bacteria. A method of treating a pierced skin area includes the step of applying to the pierced area a reconstituted ocean water mixture of sea salt and lysozyme.Type: GrantFiled: June 20, 2003Date of Patent: August 23, 2005Inventor: Edward Kolos
-
Patent number: 6926911Abstract: Chronic obstructive airway diseases are treated by administering an osmotically active compound such as a salt, sugar, sugar alcohol, or organic osmolyte to the afflicted airway surface. The compound may be administered as a liquid or dry powder aerosol formulation. Diseases that can be treated by the method include cystic fibrosis, chronic bronchitis, and ciliary dyskinesia. The formulations of the invention can also be used in conjunction with other active agents such as bronchodilators, sodium channel blockers, antibiotics, enzymes, or purinoceptor agonists on airway surfaces.Type: GrantFiled: December 21, 1999Date of Patent: August 9, 2005Assignee: The University of North Carolina at Chapel HillInventor: Richard C. Boucher, Jr.
-
Patent number: 6923987Abstract: A solid preparation for dialysis for preparing a double preparation type sodium bicarbonate solid preparation for dialysis in which there is no fear that a sugar component is decomposed or colored, and which can maintain stability and is also excellent in content homogeneity and a process for producing the same. The solid preparation for dialysis is a mixture of a first composition composed of core particles including sodium chloride and a coating layer containing one or more electrolytes, a second composition composed of core particles including a sugar that is covered with a coating layer comprising the same sugar or a different sugar, and an acid.Type: GrantFiled: September 27, 2001Date of Patent: August 2, 2005Assignee: Nipro CorporationInventors: Toshiya Kai, Kazuyuki Yamamoto, Kazutaka Fujiki, Makoto Sato
-
Patent number: 6908628Abstract: Wide spectrum disinfecting and antiseptic composition for use in the fields of human medicine, veterinary science and industry, characterized because it includes: Hydrogen peroxide, lactic acid and halogen salts (Br, I) and/or salts of heavy metals (for example, silver halides) with surfactant agents, either cationic, like chlorhexidine and/or quaternary ammonium salts, like didecyl-methyl-polyoxy-ethyl-ammonium propionate, chlorides of ammonium or compounds of ammonium propylamide or anionic, like lauryl sulphate, dodecyl sulphate or alkyl succinic salts, with suitable excipients, some of which may be ethyl or isopropyl alcohol, chlorhexidine, non-chlorinated quaternary ammonium salts, like didecyl-methyl-polyoxy-ethyl-ammonium propionate, combined or not with iodine, and/or its salts, together with excipients, some of which may be ethyl or isopropyl alcohol.Type: GrantFiled: June 10, 2002Date of Patent: June 21, 2005Assignee: OFTRAI, S.L.Inventor: Rafael Herruzo Cabrera
-
Patent number: 6881424Abstract: A highly acidic metalated organic acid composition and its preparation. The acidic composition can be prepared by mixing a monovalent or polyvalent cation and an organic acid in the presence of a strong oxyacid, wherein the resultant acidic composition is less corrosive to a ferrous metal than a solution of a mineral acid having the same acidic pH value as that of the acidic composition, and where in the acid composition is more biocidal than a mixture of the organic acid and a metal salt of the organic acid which mixture has the same acid normality value as that of the acidic composition. The acidic composition can be prepared by mixing at least one regenerating acid, at least one metal base, and at least one organic acid, wherein the amount of the regenerating acid is in excess of the equivalent amount of the metal base.Type: GrantFiled: September 5, 2000Date of Patent: April 19, 2005Assignee: Mionix CorporationInventors: Maurice Clarence Kemp, Robert Blaine Lalum, David E. Lewis, Robert H. Carpenter
-
Patent number: 6855325Abstract: Treatment for preventing and limiting the release of the chemical mediators which are responsible of the starting of cutaneous inflammatory phenomena comprising administration to a patient of hypoosmotic saline solutions.Type: GrantFiled: July 25, 2000Date of Patent: February 15, 2005Assignee: Laboratoires GOEMAR S.A.Inventors: Jean-Claude Yvin, Bénédicte Halley
-
Patent number: 6852870Abstract: The present invention is directed to a method of treating patients with major depression by administering omega-3 fatty acids. These may be administered in a substantially purified form, as part of a pharmaceutical composition, or as part of a larger molecule, e.g., a triacylglycerol, which releases free fatty acid after ingestion by a patient. The present invention is also directed to triacylglycerols which are esterified at the gamma cardon of glycerol to phosphocholine and at either the alpha or beta carbon of glycerol to an omega-3 fatty acid. These “omega-3 phoshatidylcholines” are also used in the treatment of patients with major depression.Type: GrantFiled: February 27, 2002Date of Patent: February 8, 2005Inventor: Andrew Stoll
-
Patent number: 6841172Abstract: The invention relates to methods and compositions for delivering iron to an iron-deficient patient, more particularly, to methods whereby an iron complex comprising divalent or trivalent ionic iron complexed with one or more low molecular weight anions is administered to a patient by transfer from dialysate. A complex selected according to the invention is non-polymeric; soluble in an aqueous medium; chemically stable, thereby preventing the dissociation of iron ions from the anions under conditions according to the invention; and can be well absorbed into blood and the living body. Also provided are dialysate compositions including therein an iron complex selected according to the invention, and dialysate concentrates which may be diluted to yield an inventive dialysate composition.Type: GrantFiled: August 28, 1998Date of Patent: January 11, 2005Assignee: HemoCleanse, Inc.Inventor: Stephen R. Ash
-
Patent number: 6830764Abstract: Application of an alkaline earth metal salt selected from calcium and strontium salts can steadily denature the allergens those exist in the environment without any coloring trouble on the treated material.Type: GrantFiled: March 12, 2001Date of Patent: December 14, 2004Assignees: Shinto Fine Co., Ltd., Sumitomo Chemical Co., Ltd.Inventors: Keiichiro Inui, Mariko Mikame
-
Patent number: 6827930Abstract: A sport fishing system having: a rod and reel, including fishing line; at least one fishing lure or natural bait; and a controlled released fish attractant for applying to the fishing lure or natural bait. The system may further include an applicator for applying the controlled released fish attractant to the fishing lure or natural bait. In the preferred embodiment, the controlled release fish attractant includes: an attractant and a substantially hydrophobic, film forming release agent.Type: GrantFiled: September 6, 2002Date of Patent: December 7, 2004Assignee: Carolina Lunker Sauce, L.L.C.Inventors: Stephen Russell Cobb, Michael D. Jacobson, Joseph A. Lupia
-
Patent number: 6814984Abstract: The present invention is directed to frozen biocidal compositions. Specifically, the biocidal compositions comprise a frozen aqueous solution of a plurality of ions selected from the group consisting of halide and oxyhalide ions. The frozen biocidal compositions are useful in preserving or extending the shelf-life of perishable articles.Type: GrantFiled: February 8, 2002Date of Patent: November 9, 2004Assignee: Clean Water International LLCInventors: David C. Rose, Lawrence J. Ventura
-
Patent number: 6764692Abstract: A method of treating laminitis in a horse is disclosed, comprising administering to the horse a naturally chelated trace mineral composition; promoting healthy skin, hair and hoof tissue. A method of reducing dietary intake is also disclosed, comprising administering to a horse in need thereof, effective amounts of a naturally chelated trace mineral composition. A method of preparing the chelated trace mineral composition from ocean seabed rock is further disclosed, as well as the chelated trace mineral composition.Type: GrantFiled: August 27, 2002Date of Patent: July 20, 2004Inventor: Carlos Cortelezzi
-
Publication number: 20040126435Abstract: Ectoparasites, such as fleas, ticks, mites and lice, are removed from a human or animal host after applying a composition to the affected area that causes desiccation of the organism. In one embodiment, treatment is effected by applying a substantially anhydrous composition that has a strong affinity for water. As the composition hydrates, it desiccates the pests and facilitates their mechanical removal, such as by combing.Type: ApplicationFiled: December 16, 2003Publication date: July 1, 2004Inventors: Kurt G. Van Scoik, Marcia S. Schlesinger, Frank A. Anthony
-
Patent number: 6737083Abstract: A reconstituted ocean mixture comprising, sea salt, and the purified product of reverse osmosis of water. A method is provided for treating a pierced area of a person's skin comprising applying to the pierced area a reconstituted ocean water mixture of sea salt and the product of reverse osmosis of water.Type: GrantFiled: August 16, 2001Date of Patent: May 18, 2004Inventors: Edward Kolos, Jeffrey D. Newsom
-
Patent number: 6716454Abstract: The therapeutic combination comprises as its associated active ingredients calcium in elemental form and at least one vitamin D. It also contains at least one dry and moist binder combined in synergistic quantity with at least one diluant, at least one binder, and at least one lubricant, at least one of said diluant and said binder being a sweetening agent. Advantageously, the ratio of calcium in elemental form to vitamin D, expressed in mg of elemental Ca per IU of vitamin D lies in the range 1 to 1.5, and preferably in the range 1.2 to 1.3.Type: GrantFiled: June 10, 2002Date of Patent: April 6, 2004Assignee: Laboratorie Innothera, Société AnonymeInventors: Catherine Meignant, Eric Stenger
-
Patent number: 6709744Abstract: Bioactive substantially silica-free glass material with a hydroxyapatite layer thereon is described, as well as methods for producing hydroxyapatite on a borate glass.Type: GrantFiled: August 13, 2001Date of Patent: March 23, 2004Assignees: The Curators of the University of Missouri, Vita Licensing, IncInventors: Delbert E. Day, Erik M. Erbe, Marina Richard, Joshua A. Wojcik
-
Patent number: 6709680Abstract: The invention concerns the use of iso-osmotic saline solutions, in particular obtained from sea water, to obtain a medicine for cerumenolytic treatment.Type: GrantFiled: March 26, 2001Date of Patent: March 23, 2004Assignee: Laboratories Goemar S.A.Inventors: Jean-Claude Yvin, Isabelle Cadulal, Olivier Tabary
-
Publication number: 20040037893Abstract: A liquid aqueous composition comprising (i) a factor VII polypeptide, (ii) an agent suitable for keeping pH in the range of from about 4.0 to about 8.0; (iii) an agent selected from the list of: a calcium salt, a magnesium salt, or a mixture thereof; wherein the concentration of (iii) is at least 15 mM.Type: ApplicationFiled: June 24, 2003Publication date: February 26, 2004Inventors: Birthe Lykkegaard Hansen, Michael Bech Jensen, Troels Kornfelt
-
Patent number: 6689393Abstract: A solution, in particular for hemodialysis or peritoneal dialysis that permits attaining a desired glucose concentration without affecting the concentrations of other components in the solution. The solution consists of at least three individual solutions that are combined and administered after heat sterilization. The first solution contains calcium ions, electrolyte salts and optionally glucose in a concentration of 0-1000 mM and is acidified to a pH of less than 4.0 with a physiologically tolerable acid. The second solution contains glucose in a concentration different from that of the first solution and the remaining components of the first solution in the same concentration. The third solution contains a buffer in the physiological range. Also provided is a method of preparing a solution according to the invention, where the desired mixing ratio of the separate solutions is automatically established by a dialysis machine or peritoneal dialysis cycler.Type: GrantFiled: March 22, 2000Date of Patent: February 10, 2004Assignee: Fresenius Medical Care DeutschlandInventor: Thomas Knerr
-
Patent number: 6689392Abstract: A composition for controlling growth of pathological organisms on a plant, said composition comprises an effective amount of one or more of metal ion(s); one or more of chelating agent(s); and phosphorous acid, and/or salt or hydrate thereof, said composition is in an agriculturally compatible carrier or vehicle.Type: GrantFiled: January 29, 2002Date of Patent: February 10, 2004Assignee: Agricare Ltd.Inventor: Ran Lifshitz
-
Patent number: 6680305Abstract: Physiologically acceptable aqueous solutions and methods for their use are provided. The subject solutions comprise: electrolytes; a dynamic buffering system and an oncotic agent; and do not comprise a conventional biological buffer. The subject solutions find use in a variety of applications, particularly in those applications where at least a portion of a host's blood volume is replaced with a blood substitute.Type: GrantFiled: April 20, 2000Date of Patent: January 20, 2004Assignee: BioTime, Inc.Inventors: Paul E. Segall, Hal Sternberg, Harold D. Waitz, Judith M. Segall
-
Patent number: 6663902Abstract: The present invention relates to a biocidal composition, designed for the generation of chlorine dioxide, comprising at least one iodo-compound having at least one iodine atom and a source of chlorite ions. The molar ration of chlorite ions to iodine atoms is 2 or greater. The composition finds use in a variety of applications including methods of cleaning, sanitizing, deodorizing, and disinfecting various surfaces.Type: GrantFiled: September 19, 2000Date of Patent: December 16, 2003Assignee: Ecolab Inc.Inventors: Robert D. P. Hei, David Daniel McSherry, Kim R. Smith, Keith E. Olson
-
Patent number: 6645532Abstract: Generally, the method for preventing or relieving discomfort in the ears arising from congestion and/or obstruction of in the eustachian tubes comprising or changes in middle ear pressure relative to atmospheric pressure arising from environmental conditions in an individual need of prevention or relief from discomfort in the ears comprises the steps of: 1) administering a solution of 1.5%-3.5% (preferably 2-3%) sodium chloride solution having a pH of about 6 to 7.8 (preferably 6.5-7.5) in an aqueous solution as a spray or mist into the nose, 2) minimizing discharge of the solution from the nose for at least 5 seconds, then 3) evacuating the nose under pressure.Type: GrantFiled: January 19, 2000Date of Patent: November 11, 2003Inventor: Matthew Lutin
-
Patent number: 6589566Abstract: The present invention relates to a composition for suppressing or ameliorating a symptom accompanying diminished homeostasis, comprising theanine; and a mineral composition comprising theanine and a mineral. According to the present invention, there can be provided a composition for suppressing or ameliorating the above symptoms; and a mineral composition having a reduced peculiar metal taste, of which administration is made easily.Type: GrantFiled: January 11, 2001Date of Patent: July 8, 2003Inventors: Tomoko Ueda, Yukiko Nagato, Yukiko Tanaka, Tsutomu Okubo, Kanari Kobayashi, Nobuyuki Aoi, Seiji Shu, Lekh Raj Juneja
-
Patent number: 6541038Abstract: A method for treating wood, characterized by impregnating wood with a metal-containing treating agent containing lignin and/or lignin derivatives and a metal, a metal compound, and/or a metal ion and oxidizing and/or macromolecularizing of the lignin and/or lignin derivatives in the wood to fix the metal component in the wood, and wood and woody materials obtained by the treating method. According to the method of the present invention, while effectively utilizing lignins, lignosulfonic acids, or lignosulfonic acid salts, leaching of the metal component can be suppressed to a low level to thereby retain the effects due to the incorporation of the metal components for a prolonged period.Type: GrantFiled: May 25, 2000Date of Patent: April 1, 2003Assignee: SDS Biotech K.K.Inventors: Keijitsu Tanaka, Hirobumi Aoki, Takashi Echigo
-
Publication number: 20030021819Abstract: The present invention is directed to the a composition and method for microbial and odor control. In one embodiment, the method includes mixing amorphous calcium silicate impregnated with a chlorite salt to form a reactant, combining the reactant with an activator to form the composition, and applying the composition to the treatment area. The present invention also includes the preparation of a product usable as a disinfectant and deodorizer, wherein the product includes a mixture of an amorphous and a chlorite salt and wherein the product is packaged as a tablet, permeable sachet, or a permeable patch attachable to a plastic bag. The present invention may also be applied using several methods to reduce the spoilage of produce. The present invention further includes a method for producing chlorine dioxide in accordance with a step-function release profile.Type: ApplicationFiled: April 18, 2002Publication date: January 30, 2003Applicant: Bio-Cide International, Inc.Inventors: Neeraj Khanna, Robert J. Vahlberg, Theodore D. Head, Bryan D. Lowery
-
Publication number: 20020176885Abstract: Described herein is a physiologically-balanced, ionized, acidic solution. Typically the solution is prepared by the electrolysis of a solution comprising a mixture of inorganic salts in physiologically balanced proportions. This invention also relates to a methodology for use of the solutions, including a specialized bandage which may be used in combination with the solutions, or with other topically applied materials. A mixture of inorganic salts and, optionally minerals, (such as metallic elements, for example and not by way of limitation) is used in order to mimic the electrolyte concentration and mixture of body fluid in an isotonic state. The solution typically comprises halide salts of sodium, potassium, calcium, and other cations. Typically the halide is fluoride, chloride, bromide, or iodide, and most typically chloride. The concentrations of these salts in combination with particular minerals are such that they give the electrolyzed composition its unique properties.Type: ApplicationFiled: April 4, 2002Publication date: November 28, 2002Inventors: Ramin Najafi, Suzanne M. Bernard
-
Patent number: 6475529Abstract: The present invention provides devices and methods for stabilizing bicarbonate-based solutions for peritoneal dialysis or hemofiltration. The bicarbonate-based solutions of the present invention are formulated and stored in at least two parts—an alkaline bicarbonate concentrate and an acidic concentrate. The alkaline bicarbonate concentrate is adjusted to have a pH of about 8.6 to 10.0. The acidic concentrate is adjusted to have a stable, acidic pH ranging from about 1.0 to 3.0. Upon mixing, although some variation in the pH of the mixed bicarbonate solution exists, the inventors have discovered that with the appropriate selection of the parameters of the concentrates, the pH of the mixed solution is always within an acceptable physiological range.Type: GrantFiled: July 30, 2001Date of Patent: November 5, 2002Assignee: Baxter International Inc.Inventors: Annick Duponchelle, Dirk Faict, Patrick Balteau, Jean-Pierre Hartman, Leo Martis, Francesco Peluso
-
Patent number: 6468550Abstract: A method of improving the photochromishm of a composition comprising at least one photochromic compound with an ionic conductor, and the composition thereof. The composition may, in particular, be in the form of a care and/or make-up product for the skin, a suncare or self-tanning product, or a haircare product.Type: GrantFiled: August 25, 1998Date of Patent: October 22, 2002Assignee: L'Oreal, S.A.Inventor: Christophe Remy
-
Patent number: 6451352Abstract: The invention concerns the use of iso-osmotic saline solutions in particular obtained from sea water, to obtain a medicine designed for a treatment preventing and limiting the release of chemical mediators responsible for causing inflammatory phenomena in the human respiratory tracts.Type: GrantFiled: May 24, 2001Date of Patent: September 17, 2002Assignee: Laboratoires Goemar S.A.Inventors: Jean-Claude Yvin, Olivier Tabary, Jacky Jacquot, Edith Puchelle
-
Publication number: 20020114772Abstract: The invention features methods of promoting hair growth in a subject. The methods include inducing or mimicking the effects of Wnt promoted signal transduction, e.g., by increasing the level of Wnt protein or administering an agent which mimics an effect of Wnt promoted signal transduction, e.g., by administering lithium chloride. Methods of inhibiting hair growth are also provided.Type: ApplicationFiled: March 30, 2001Publication date: August 22, 2002Inventors: Bruce A. Morgan, Jiro Kishimoto, Robert Burgeson
-
Patent number: 6413551Abstract: A termiticide which comprises at least one compound which in the presence of a termite produces a termiticidally effective amount of hydrogen sulfide.Type: GrantFiled: January 26, 2001Date of Patent: July 2, 2002Inventor: David William Holloway
-
Patent number: 6406709Abstract: Compositions for inhibiting nematocyst or polar capsule discharge are provided in the form of an effective amount of antihistamine, an effective amount of antihistamine and an effective amount of at least one cation, or an effective amount of at least one cation. The compositions can be in the form of ointments or can be added to the environment surrounding the nematocysts or polar capsules. Methods of inhibiting nematocyst or polar capsule discharge using the compositions of the invention are also provided.Type: GrantFiled: April 6, 2000Date of Patent: June 18, 2002Assignee: Nidaria Technology Ltd.Inventor: Amit Lotan
-
Patent number: 6407038Abstract: A method for controlling Tylenchid plant-parasitic nematodes through application of an effective amount of an alkaline-stabilized sludge is described. In accordance with particular embodiments, the alkaline-stabilized sludge may be applied to the plant, seed or locus thereof.Type: GrantFiled: June 16, 2000Date of Patent: June 18, 2002Assignee: Her Majesty the Queen in right of Canada, as represented by c/o Minister of Agriculture and Agri-Food CanadaInventors: Thomas William Welacky, Edward Topp
-
Patent number: 6395311Abstract: The present invention provides a novel vehicle for the delivery of biologically active agents. The vehicle, Maxcell™, is formulated from a novel combination of natural plant extracts and is comprised of Aloe vera polysaccharide fraction Immuno-10, cAMP, piperine, calcium phosphate and glycyrrhizinic acid.Type: GrantFiled: April 29, 1999Date of Patent: May 28, 2002Assignee: Univera Pharmaceuticals, Inc.Inventor: Qi Jia
-
Publication number: 20020061334Abstract: A solid preparation for dialysis for preparing a double preparation type sodium bicarbonate solid preparation for dialysis in which there is no fear that a sugar is decomposed or colored, and which can maintain stability and also is excellent in content homogeneity and a process for producing the same. The solid preparation for dialysis is a mixture of a first composition composed of core particles including sodium chloride that are coated with a coating layer containing one or more electrolytes, a second composition composed of core particles including a sugar that are covered with a coating layer containing one or more electrolytes, and an acid.Type: ApplicationFiled: September 27, 2001Publication date: May 23, 2002Inventors: Toshiya Kai, Kazuyuki Yamamoto, Kazutaka Fujiki, Makoto Sato
-
Patent number: 6387412Abstract: A storage stable magnesium oxychloride coated granular animal feed mineral supplement composition resistant to disintegration cause by moisture absorption and attrition, comprising granular mineral nutrients useful as animal feed supplements and magnesium oxychloride coatings amounting to between 0.5 and 10.0 percent of the weight of the granules, formed on the granules of mineral nutrients by coreaction of magnesium chloride and magnesium oxide. An additional coating of between 0.2 and 2.0 percent magnesium stearate formed on the magnesium oxychloride may be used to decrease the rate of wetting of the granular animal feed mineral supplements.Type: GrantFiled: April 14, 2000Date of Patent: May 14, 2002Assignee: Agri-Nutrients Technology Group, Inc.Inventor: William P. Moore
-
Patent number: RE38604Abstract: Electrolyte solutions are provided which are useful in electrolyte and fluid therapy, parenteral nutrition and dialysis. The Na:Cl ratio is normalized, plasma and cellular pH are normalized and cellular cofactor ratios are normalized in a manner which decreases toxicity over prior art solutions.Type: GrantFiled: February 1, 2002Date of Patent: September 28, 2004Assignee: BTG International LimitedInventor: Richard L. Veech